Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Analysis of the clinical and epidemiological profile of leprosy in Brazil and Major Regions

Sczmanski ADS, Pazin L, Sakae TM, et al. Elsevier BV. Anais Brasileiros de Dermatologia. 2025; 100 (4) : 8.
Download PDF
Publication

Safety and Efficacy Assessment of Two New Leprosy Skin Test Antigens: Randomized Double Blind Clinical Study

Rivoire BL, Groathouse NA, TerLouw S, et al. Public Library of Science (PLoS). PLoS Neglected Tropical Diseases. 2014; 8 (5) : 13.
Download PDF
Publication

Early Detection of Common Skin Diseases, Including Leprosy: Development and Validation of an Awareness Questionnaire

Abqari U, Atoillah Isfandiari M, Dharmawan Y, et al. Frontiers Media SA. International Journal of Public Health. 2025;
Download PDF
Publication

Awareness of leprosy in East Seram District community: A cross-sectional study from Maluku Province, Indonesia

Titaley CR, Astuty E, Ahmad NHDF, et al. Veterinary World. International Journal of One Health. 2025;
Download PDF
Publication

Access and accessibility in Primary Health Care: experiences of individuals affected by leprosy

Souza CVGD, Sá CRFD, Vale CCD, et al. FapUNIFESP (SciELO). Escola Anna Nery. 2025;
Download PDF
Publication

Capacitação para a equipe de saúde da atenção primária sobre a hanseníase na Atenção Primária à Saúde: revisão de escopo

Bolorino N, Tiroli CF, Ravagnani JKDS, et al. Brazilian Journals. Caderno Pedagógico. 2025; 22 (6) : 26.
Download PDF
Publication

Bedaquiline Activity against Leprosy

Fomba A, Haidara FC, Kodio M, et al. Massachusetts Medical Society. New England Journal of Medicine. 2025; 392 (21) : 2174-2176.
Download PDF
Publication

Unprecedented in vivo activity of telacebec against Mycobacterium leprae

Chauffour A, Cambau E, Pethe K, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2025; 19 (5) : 1-11.
Download PDF
Publication

Mycobacterium leprae Slide Positivity at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia: Seven Years Retrospective Study

Erkihun M, Assefa A, Legese B, et al. Wiley. Health Science Reports. 2025; 8 (4) : 7.
Download PDF
Publication

Lessons From the Past, Hope for the Future: A Qualitative Study on the Lives of Leprosy-Affected Residents of a Leprosy Settlement in Malaysia

Abdul Rahman N, Rajaratnam V, Rafee NHM, et al. SAGE Publications. Qualitative Health Research. 2025;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 21
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD